Tarang Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tarang Sharma has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Christine Årdal
Norwegian Institute of Public Health, Oslo, Norway
1 shared publication- Joan Rovira
Department of Economic Theory, University of Barcelona, Barcelona, Spain
1 shared publication - Joav Merrick
National Institute of Child Health and Human Development, Division for Mental Retardation Ministry of Social Affairs and Social Services
1 shared publication Jorge Mestre-Ferrandiz
Department of Economics, University Carlos III, Madrid, Spain
1 shared publication- Klazien Matter-Walstra
Department HTA Swiss Federal Office of Public Health, Bern, Switzerland
1 shared publication Krista Kruja
Evidence Link, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
Tarang Sharma and colleagues argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable and sustainable access to costly medicines
Open AccessManaging costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
Tarang Sharma and colleagues argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable and sustainable access to costly medicines
- Open Access
- 2 April 2020
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 18 (1) , 1-6
Cost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow
Since its inception in 2003, Cost Effectiveness and Resource Allocation journal has come a long way over the past 18 years. Possibly much longer than many of its contemporaries in the blossoming science of health economics might have anticipated. Today, entering 2020 it celebrates the Age of Maturity. We believe that in the third decade of XXI century the interdisciplinary science of health economics, will rejuvenate and come back to us younger than ever from its early historical roots almost a century ago. The spreading of economic globalization in several distinctive ways, either led by multinational business corporations or newly emerged Asian leadership, or both, is likely to make challenges for contemporary health systems far more serious. The fourth industrial revolution (cyber physical systems and artificial intelligence technology) and accelerated innovation in the field of E-Health and digital health, will probably change the workflow in medical and health care, and inevitably transform the labour market in the upcoming decades. So, let us be up to the task. Let us provide academic centres, industry-sponsored pharmaceutical and medical device innovation hubs, and governing authorities alike, with a powerful forum for debate on cost-effective resource allocation in the years to come.
- 2 April 2020
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 18 (1) , 1-6
Open AccessCost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow
Since its inception in 2003, Cost Effectiveness and Resource Allocation journal has come a long way over the past 18 years. Possibly much longer than many of its contemporaries in the blossoming science of health economics might have anticipated. Today, entering 2020 it celebrates the Age of Maturity. We believe that in the third decade of XXI century the interdisciplinary science of health economics, will rejuvenate and come back to us younger than ever from its early historical roots almost a century ago. The spreading of economic globalization in several distinctive ways, either led by multinational business corporations or newly emerged Asian leadership, or both, is likely to make challenges for contemporary health systems far more serious. The fourth industrial revolution (cyber physical systems and artificial intelligence technology) and accelerated innovation in the field of E-Health and digital health, will probably change the workflow in medical and health care, and inevitably transform the labour market in the upcoming decades. So, let us be up to the task. Let us provide academic centres, industry-sponsored pharmaceutical and medical device innovation hubs, and governing authorities alike, with a powerful forum for debate on cost-effective resource allocation in the years to come.